Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06929637Not yet recruiting
Open-label trial of compound amino acids injection (18aa-vii) in delayed graft function (DGF) (2 arms), sponsored by University Hospital Martin. Primary endpoint: Improving graft function at 3 months. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06929637.